Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

SELL
$32.31 - $52.32 $4.06 Million - $6.57 Million
-125,630 Reduced 72.87%
46,777 $1.7 Million
Q3 2023

Nov 14, 2023

BUY
$47.3 - $70.6 $972,440 - $1.45 Million
20,559 Added 13.54%
172,407 $8.32 Million
Q2 2023

Aug 11, 2023

BUY
$48.26 - $78.59 $1.4 Million - $2.29 Million
29,098 Added 23.71%
151,848 $10.4 Million
Q1 2023

May 12, 2023

BUY
$46.97 - $58.27 $354,623 - $439,938
7,550 Added 6.55%
122,750 $5.95 Million
Q4 2022

Feb 10, 2023

BUY
$52.05 - $65.0 $6 Million - $7.49 Million
115,200 New
115,200 $6.94 Million
Q1 2018

May 15, 2018

SELL
$27.95 - $45.04 $5.14 Million - $8.29 Million
-184,063 Closed
0 $0
Q4 2017

Feb 13, 2018

SELL
$35.44 - $63.76 $419,822 - $755,300
-11,846 Reduced 6.05%
184,063 $6.9 Million
Q3 2017

Nov 14, 2017

BUY
$53.83 - $67.75 $10.5 Million - $13.3 Million
195,909
195,909 $12.7 Million

Others Institutions Holding PRTA

About PROTHENA CORP PUBLIC LTD CO


  • Ticker PRTA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,922,800
  • Market Cap $714M
  • Description
  • Prothena Corporation plc, a late-stage clinical company, focuses on discovery and development of novel therapies for life-threatening diseases in the United States. The company is involved in developing Birtamimab, an investigational humanized antibody that is in Phase III clinical trial for the treatment of AL amyloidosis; Prasinezumab, a human...
More about PRTA
Track This Portfolio

Track Sectoral Asset Management Inc Portfolio

Follow Sectoral Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sectoral Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Sectoral Asset Management Inc with notifications on news.